Healthcare Industry News:  Glaucoma 

Devices Ophthalmology

 News Release - March 5, 2008

Paradigm Medical Industries Introduces Advances on the LD400 Full-Field Autoperimetry System

SALT LAKE CITY--(HSMN NewsFeed)--Paradigm Medical Industries, Inc. (OTCBB: PMED.OB ), a leader in Glaucoma diagnostic and management devices, is introducing new advance developments to the Paradigm-Dicon LD400 full-field autoperimetry system. The LD400 is used to measure patient visual fields to determine the severity of Glaucoma and to aid in managing the disease.

“The Company has redesigned what we believe to be the industry’s superior autoperimeter,” said Paradigm Medical’s Chief Executive Officer, Raymond Cannefax. “Demand for our proprietary Paradigm-Dicon LD400 product continues to be extremely high in the U.S. and globally, and this updated product incorporates all the changes the medical profession has requested. We believe we are also broadening the market for autoperimeters.

“The kinetic fixation feature of the LD400 Autoperimeter is unique and exclusive to perimetry and offers full kinetic fixation for greater reliability, improved test results and patient comfort,” Mr. Cannefax added. “Kinetic fixation reduces patient fatigue and increases patient interest resulting in higher exam accuracy. The Paradigm-Dicon LD400 provides the highest standard of care from a full-field autoperimeter.”

New developments to the LD400 include redesigning the existing software, assuring device compatibility with a variety of printers and making the device fully networkable. All connections will be through USB ports. The patient data base will be similar to the Paradigm P60 Ultrasound BioMicroscope (UBM) and the printed examination reports will be grayscale, making them much easier to read.

Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and Glaucoma detection and management products.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainty and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.

Source: Paradigm Medical Industries

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.